An In Vivo Mouse Excisional Wound Model of Scarless Healing

    Amy S. Colwell, Thomas M. Krummel, Michael T. Longaker, H. Peter Lorenz
    Image of study
    TLDR Mice healed without scars as fetuses but developed scars as adults, suggesting scarless healing might be replicated with further research.
    In 2006, researchers developed a mouse model to study scarless wound healing by creating 1-mm excisional wounds on mouse fetuses at gestational days 16.5 and 18.5, and comparing them to 2-mm open wounds on 3-week-old postnatal mice. They found that wounds on day 16.5 fetuses healed within 48 hours with no scarring and hair follicle regeneration, while day 18.5 fetuses and postnatal mice developed scars without hair follicle regeneration. The study concluded that the mouse model is effective for studying scarless healing and that manipulating scarring in adults to mimic fetal healing is possible. The research also indicated that scarless healing involves multiple cytokines and signaling molecules, and future work will focus on identifying specific skin genes for targeted manipulation to achieve scarless healing. The study was supported by various medical and research institutions.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 17 results

      community Comprehensive Microneedling Guide

      in Microneedling  295 upvotes 2 years ago
      Microneedling for hair restoration involves daily use of a 0.3 mm device and weekly use of a 0.5 mm device. Combining microneedling with Minoxidil can enhance hair growth.

      community Verteporfin and Microneedling

      in Treatments 5 months ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.

      community Dr. Bloxham's Verteporfin Trial

      in Research/Science  29 upvotes 1 year ago
      Dr. Bloxham's trial is testing verteporfin on hair transplant patients to see if it can improve hair regrowth in treated areas. People are discussing the potential for follicle regeneration, expected results timeline, and concerns about side effects like cancer.

    Related Research

    1 / 1 results